News

Wegovy is the brand name for semaglutide which is licensed and approved for managing ... such as a condom or switching to a ...
DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's ...
Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.
Hims & Hers Health shows impressive operating leverage and a scalable business model, with massive growth potential from new ...
While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...
A MUM has shared a downside of her epic weight loss transformation after being on Mounjaro for over two months. Scottish mum Kirsty took to TikTok after she shed almost a staggering 5 stone while ...
Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...
Houston-based Empower Pharmacy has repeatedly been admonished by the FDA for failing to follow federal rules that ensure drug ...
Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — ...
One person was killed and 32 people were injured, including two critically, when a tour bus and a sport utility vehicle ...
Today, companies across sectors including Tata Steel, Ather Energy, Bajaj Electricals, PVR INOX, Raymond, Siyaram Silk Mills, ...
Short interest in Hims & Hers Health Inc rose to a record high, even as shares surged following strong first-quarter results.